当前位置: 首页 > 期刊 > 《医药产业资讯》 > 202026
编号:13808000
利奈唑胺个体化给药研究进展(3)
http://www.100md.com 2020年9月15日 《中国医药导报》 202026
     [參考文献]

    [1] Cao B,Tan TT,Poon E,et al. Consensus statement on the management of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Asia [J]. Clin Respir J,2015,9(2):129-142.

    [2] Carreno JJ,Kenney RM,Divine G,et al. Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT)[J]. Ann Pharmacother ......
上一页1 2 3

您现在查看是摘要页,全文长 3279 字符